STOCKSCREENR
Log In

QGEN

NYSE

Qiagen N.V.

$41.54+0.62(+1.52%)Mkt Cap: $8.56B

Key Stats

Market Cap

$8.56B

P/E Ratio

20.36

EPS

$2.04

Dividend Yield

5.97%

52-Week Range

$38.13 — $57.82

Volume

1.45M

Avg Volume

2.40M

Beta

0.71

Valuation

P/E (TTM)

20.36

Forward P/E

16.51

PEG Ratio

3.70

P/S (TTM)

4.39

P/B (TTM)

2.45

P/FCF

81.44

EV/EBITDA

37.73x

EV/Sales

—

Financial Health

ROE (TTM)

0.12%

ROA (TTM)

0.07%

ROIC

0.02%

Gross Margin

0.62%

Operating Margin

0.25%

Net Margin

0.24%

Debt/Equity

0.44

Current Ratio

3.90

Growth

EPS Growth (YoY)

+0.36%

Revenue Growth (YoY)

+0.09%

EPS Growth (3Y)

-0.65%

EPS Growth (5Y)

+0.90%

Sales Growth (3Y)

-0.01%

Sales Growth (5Y)

+0.03%

EPS Est (This Year)

$2.52

EPS Est (Next Year)

$2.77

Dividends

Dividend Yield

—

Annual Dividend

$2.41

Payout Ratio

0.42%

Frequency

—

Ex-Dividend Date

2026-01-08

Cash/Share

$5.29

Analyst Consensus

3.0

Hold

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$50.00$53.50$59.00
LowMedianHigh

Consensus Target: $54.33(30.8% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

206.00M

Float

204.72M

Free Float %

99.38%

Technicals

RSI (14)

23.12

SMA 20

$52.06

SMA 50

$49.30

SMA 200

$47.84

ATR (14)

1.51

Volatility (Week)

0.01%

Volatility (Month)

0.04%

Pattern

—

Performance

1 Day

+0.59%

1 Week

-1.56%

1 Month

+5.78%

3 Months

+17.26%

6 Months

+6.39%

1 Year

—

YTD

+7.38%

All-Time High

$57.82

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

NL

Exchange

NYSE

IPO Date

1996-06-28

Employees

5700

CEO

Thierry Bernard

Index Membership

—

Website

https://www.qiagen.com

Qiagen N.V. (QGEN) is a healthcare company in the medical - diagnostics & research industry listed on the NYSE. With a market capitalization of $8.56B, a P/E ratio of 20.36, and a dividend yield of 5.97%, QGEN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare QGEN against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0KHE.L

Revvity, Inc.

$88.87

+3.35%

$9.89B

LH

Labcorp Holdings Inc.

$270.62

+1.41%

$22.43B

ILMN

Illumina, Inc.

$120.84

+1.31%

$18.48B

NTRA

Natera, Inc.

$198.38

+0.35%

$28.12B

MEDP

Medpace Holdings, Inc.

$455.15

+0.33%

$12.92B

RDNT

RadNet, Inc.

$63.63

-0.73%

$4.94B

Frequently Asked Questions

What is Qiagen N.V.'s P/E ratio?

Qiagen N.V. (QGEN) has a trailing twelve-month (TTM) P/E ratio of 20.36. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Qiagen N.V. pay a dividend?

No, Qiagen N.V. (QGEN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Qiagen N.V.'s market cap?

Qiagen N.V. (QGEN) has a market capitalization of $8.56 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about QGEN?

Wall Street analysts have a consensus "Hold" rating on Qiagen N.V. (QGEN) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $54.33 implies 30.8% upside from the current price.

How has QGEN performed this year?

Qiagen N.V. (QGEN) has returned +7.38% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.